Indianapolis, April 01, 2025 (GLOBE NEWSWIRE) — As autism prevalence continues to rise, the importance of education and awareness for the public also continues to grow. In addition to celebrating 20 years of service in 2025, Hopebridge Autism Therapy Centers is preparing for an exciting month ahead: World Autism Month. April is World Autism Month, […]
(CNSX:NXT.CN),(Boerse Frankfurt – Freiverkehr:Z12),(OTC US:NXTDF),(OTCQB:NXTDF), Fredericton, New Brunswick, April 01, 2025 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company“) is pleased to announce that it is undertaking a non-brokered private placement of up to 10,000,000 special warrants (the “Special Warrants“) and/or common shares of the Company (the “Shares“, and
(TSX-V:DGHI),(NASDAQ:DGHI),(NASDAQ:DGXX),(TSX-V:DGX), MIAMI, April 01, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company“) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to provide unaudited comparative Bitcoin (“BTC“) production results for the first quarter ended March 31, 2025, combined with an operations
(NASDAQ:LDTC), QUEBEC CITY, Canada, April 01, 2025 (GLOBE NEWSWIRE) — LeddarTech(R) Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, LeddarVision(TM), today announced that it has entered into: a seventeenth amending agreement (the “Seventeenth Amending Agreement”) with Federation des caisses Desjardins du Quebec
(NASDAQ:KRRO), CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) — Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today the appointment of Loic Vincent, Ph.D., as the Company's Chief Scientific Officer. “We are
(NASDAQ:SONN), PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced with deep and profound sadness the tragic passing of Pankaj Mohan, Ph.D., Sonnet Founder and Chief Executive Officer. The Company's Board of Directors
(NYSE:AMPY), HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify” or the “Company”) announced that Institutional Shareholder Services (“ISS”), a leading independent proxy advisory firm, has recommended that shareholders vote “FOR” the Company's proposed merger with Juniper Capital's upstream Rocky Mountain portfolio companies. The Company issued the following statement in response
(NASDAQ:CGTX), PURCHASE, N.Y., April 01, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented biomarker results from the Phase 2 SHINE (COG0201) study of zervimesine (CT1812) in mild-to-moderate Alzheimer's disease at the AD/PD(TM) 2025 Alzheimer's & Parkinson's Diseases Conference taking place
(NASDAQ:ABEO), CLEVELAND, April 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On March 31, 2025, the Compensation Committee of Abeona's Board of Directors granted restricted stock
(NASDAQ:KURA), SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the Stifel 2025 Virtual Targeted Oncology Forum. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to